Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?

被引:156
作者
Bots, Michiel L.
Baldassarre, Damiano
Simon, Alain
de Groot, Eric
O'Leary, Daniel H.
Riley, Ward
Kastelein, John J.
Grobbee, Diederick E.
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands
[2] Univ Milan, Dept Pharmacol Sci, E Grossi Paoletti Ctr, Milan, Italy
[3] Hop Broussais, Assistance Publ Hop Paris, Ctr Med Prevent Cardiovasc, Fac Med Rene Descartes, F-75674 Paris, France
[4] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[5] Tufts Univ, Sch Med, Dept Radiol, Boston, MA 02111 USA
[6] Wake Forest Univ, Sch Med, Dept Neurol, Winston Salem, NC 27109 USA
关键词
carotid atherosclerosis; trials; surrogate endpoints; hypertension; statin;
D O I
10.1093/eurheartj/ehl482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Measurement of change in carotid intima-media thickness (CIMT) has been proposed as an atternative for the occurrence of cardiovascular (CV) events in the assessment of therapeutic interventions. Nevertheless, criticism has been voiced based on observations indicating a weak relation between CIMT and coronary atherosclerosis as well as on the virtual absence of data showing that progression of CIMT indeed predicts coronary artery disease (CAD) and stroke. Methods and results We set out to review the evidence on these issues by performing a literature search on these topics. Of the 34 studies on the relation of CIMT with coronary atherosclerosis, as assessed by angiography (n=33) or intravascular ultrasound (n=1), 30 showed a modest positive relationship; the magnitude of which was similar to that found in autopsy studies. Of all studies on CIMT and future CV events (n = 18), 17 showed graded positive relationships. At present, only one study has provided evidence on the relation of change in CIMT and future CV events, showing an increased risk with CIMT progression. The paucity of data on progression and future CV risk is partly attributable to time windows required to complete these studies. Conclusion The modest relation between CIMT and coronary atherosclerosis most likely reflects variability in atherosclerosis development between the vascular beds rather than limitations of CIMT measurements. Additional data on the relation between change in CIMT and future CV events is required and currently is in progress.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 104 条
[1]   CAROTID INTIMA-MEDIA THICKNESS IS ONLY WEAKLY CORRELATED WITH THE EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE [J].
ADAMS, MR ;
NAKAGOMI, A ;
KEECH, A ;
ROBINSON, J ;
MCCREDIE, R ;
BAILEY, BP ;
BENFREEDMAN, S ;
CELERMAJER, DS .
CIRCULATION, 1995, 92 (08) :2127-2134
[2]   Relation between coronary artery disease, risk factors and intima-media thickness of carotid artery, arterial distensibility, and stiffness index [J].
Alan, S ;
Ulgen, MS ;
Ozturk, O ;
Alan, B ;
Ozdemir, L ;
Toprak, N .
ANGIOLOGY, 2003, 54 (03) :261-267
[3]   Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis [J].
Amarenco, P ;
Labreuche, J ;
Lavallée, P ;
Touboul, PJ .
STROKE, 2004, 35 (12) :2902-2909
[4]   Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives [J].
Anderssen, SA ;
Hjelstuen, AK ;
Hjermann, I ;
Bjerkan, K ;
Holme, I .
ATHEROSCLEROSIS, 2005, 178 (02) :387-397
[5]   Correlations between vascular calcification and atherosclerosis: A comparative electron beam CT study of the coronary and carotid arteries [J].
Arad, Y ;
Spadaro, LA ;
Roth, M ;
Scordo, J ;
Goodman, K ;
Sherman, S ;
Lledo, A ;
Lerner, G ;
Guerci, AD .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1998, 22 (02) :207-211
[6]   Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria [J].
Asselbergs, FW ;
van Roon, AM ;
Hillege, HL ;
de Jong, PE ;
Gans, ROB ;
Smit, AJ ;
van Gilst, WH .
STROKE, 2005, 36 (03) :649-653
[7]  
Balbarini A, 2000, ANGIOLOGY, V51, P269
[8]  
BALDASSARRE R, 2004, 15 INT S DRUGS AFF L
[9]  
Barth Jacques D., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P129, DOI 10.2174/1568006043336339
[10]   Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease [J].
Beishuizen, ED ;
Van de Ree, MA ;
Jukema, JW ;
Tamsma, JT ;
Van der Vijver, JCM ;
Meinders, AE ;
Putter, H ;
Huisman, MV .
DIABETES CARE, 2004, 27 (12) :2887-2892